Impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to Strongyloides stercoralis in children

Journal Publication ResearchOnline@JCU
Marks, Michael;Gwyn, Sarah;Toloka, Hilary;Kositz, Christian;Asugeni, James;Asugeni, Rowena;Diau, Jason;Kaldor, John M.;Romani, Lucia;Redman-Maclaren, Michelle;MacLaren, David;Solomon, Anthony W.;Mabey, David C.W.;Steer, Andrew C.;Martin, Diana
Michelle Redman-MacLaren
Abstract

The prevalence of antibodies to Strongyloides stercoralis was measured in 0-12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P†=†.019), demonstrating collateral benefits of ivermectin MDA in this setting.

Journal

Clinical Infectious Diseases

Publication Name

N/A

Volume

71

ISBN/ISSN

1537-6591

Edition

N/A

Issue

12

Pages Count

3

Location

N/A

Publisher

University of Chicago Press

Publisher Url

N/A

Publisher Location

N/A

Publish Date

N/A

Url

N/A

Date

N/A

EISSN

N/A

DOI

10.1093/cid/ciaa584